National Research Co. (NASDAQ:NRC) Shares Acquired by Seizert Capital Partners LLC

Seizert Capital Partners LLC lifted its holdings in shares of National Research Co. (NASDAQ:NRC) by 12.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,892 shares of the company’s stock after acquiring an additional 2,224 shares during the period. Seizert Capital Partners LLC’s holdings in National Research were worth $351,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Charles Schwab Investment Management Inc. lifted its position in National Research by 0.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 124,711 shares of the company’s stock worth $2,200,000 after acquiring an additional 970 shares during the period. US Bancorp DE lifted its holdings in shares of National Research by 2.2% during the third quarter. US Bancorp DE now owns 45,932 shares of the company’s stock worth $1,050,000 after purchasing an additional 992 shares during the period. Principal Financial Group Inc. grew its position in National Research by 10.7% in the 4th quarter. Principal Financial Group Inc. now owns 12,018 shares of the company’s stock valued at $212,000 after buying an additional 1,161 shares during the last quarter. JPMorgan Chase & Co. increased its stake in National Research by 8.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 17,194 shares of the company’s stock valued at $393,000 after buying an additional 1,373 shares during the period. Finally, SG Americas Securities LLC raised its position in National Research by 35.0% during the 4th quarter. SG Americas Securities LLC now owns 7,298 shares of the company’s stock worth $129,000 after buying an additional 1,893 shares during the last quarter. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Stock Up 0.9 %

Shares of NASDAQ:NRC opened at $14.23 on Thursday. National Research Co. has a fifty-two week low of $13.74 and a fifty-two week high of $40.77. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. The firm’s 50-day simple moving average is $16.90 and its 200-day simple moving average is $18.92. The company has a market cap of $334.06 million, a price-to-earnings ratio of 13.55 and a beta of 0.47.

National Research (NASDAQ:NRC) last announced its quarterly earnings data on Monday, January 27th. The company reported $0.28 earnings per share for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.